Line K. Johnson
Tonsberg, 3103, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
A multi-omics microbiome signature is associated with the benefits of gastric bypass surgery and is differentiated from diet induced weight loss through 2 years of follow-up.
Journal: Mucosal immunology
Published: October 14, 2024
Effect of gastric bypass versus sleeve gastrectomy on the remission of type 2 diabetes, weight loss, and cardiovascular risk factors at 5 years (Oseberg): secondary outcomes of a single-centre, triple-blind, randomised controlled trial.
Journal: The lancet. Diabetes & endocrinology
Published: July 04, 2024
Gastric Bypass vs Diet and Cardiovascular Risk Factors: A Nonrandomized Controlled Trial.
Journal: JAMA surgery
Published: July 03, 2024
Oral Drug Dosing After Gastric Bypass and Diet-Induced Weight Loss: Simpler Than We Think? Lessons Learned From the COCKTAIL Study.
Journal: Clinical pharmacology and therapeutics
Published: January 31, 2024
Digoxin Pharmacokinetics in Patients with Obesity Before and After a Gastric Bypass or a Strict Diet Compared with Normal Weight Individuals.
Journal: Clinical pharmacokinetics
Published: October 08, 2023
A pilot study of implementation of endoscopic sleeve gastroplasty (ESG) in Norway.
Journal: Scandinavian journal of gastroenterology
Published: May 02, 2023
Neither Gastric Bypass Surgery Nor Diet-Induced Weight-Loss Affect OATP1B1 Activity as Measured by Rosuvastatin Oral Clearance.
Journal: Clinical pharmacokinetics
Published: February 28, 2023
Changes in dietary intake, food tolerance, hedonic hunger, binge eating problems, and gastrointestinal symptoms after sleeve gastrectomy compared with after gastric bypass; 1-year results from the Oseberg study-a randomized controlled trial.
Journal: The American journal of clinical nutrition
Published: June 29, 2022
Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome P450 in patients with obesity.
Journal: Clinical and translational science
Published: May 30, 2022
Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range.
Journal: European journal of clinical pharmacology
Published: April 06, 2022
Short- and long-term effects of body weight, calorie restriction and gastric bypass on CYP1A2, CYP2C19 and CYP2C9 activity.
Journal: British journal of clinical pharmacology
Published: January 23, 2022
A novel intragastric balloon for treatment of obesity and type 2 diabetes. A two-center pilot trial.
A novel intragastric balloon for treatment of obesity and type 2 diabetes. A two-center pilot trial.
Journal: Scandinavian journal of gastroenterology
Published: October 29, 2021
Last Updated: 09/26/2026